<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="782" width="593">
	<fontspec id="font0" size="9" family="AdvC2866" color="#231f20"/>
	<fontspec id="font1" size="10" family="AdvSMyr-SB" color="#231f20"/>
	<fontspec id="font2" size="9" family="AdvC2867" color="#231f20"/>
	<fontspec id="font3" size="9" family="AdvPS586B" color="#231f20"/>
	<fontspec id="font4" size="9" family="AdvP4C4E74" color="#231f20"/>
	<fontspec id="font5" size="8" family="AdvPSMy-B" color="#231f20"/>
	<fontspec id="font6" size="8" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font7" size="7" family="AdvPSMy-R" color="#231f20"/>
	<fontspec id="font8" size="5" family="AdvPSMy-R" color="#231f20"/>
<text top="426" left="45" width="243" height="8" font="font0" id="p1_t1" reading_order_no="12" segment_no="7" tag_type="text">However, they were less advantaged in that fewer of them had</text>
<text top="438" left="45" width="113" height="8" font="font0" id="p1_t2" reading_order_no="13" segment_no="7" tag_type="text">a radio in their compounds.</text>
<text top="456" left="45" width="118" height="10" font="font1" id="p1_t3" reading_order_no="14" segment_no="9" tag_type="title">Outcomes and Estimation</text>
<text top="469" left="45" width="243" height="8" font="font0" id="p1_t4" reading_order_no="15" segment_no="10" tag_type="text">There were no signiﬁcant differences in the cognitive</text>
<text top="480" left="45" width="243" height="8" font="font0" id="p1_t5" reading_order_no="16" segment_no="10" tag_type="text">function scores between the two arms, with or without</text>
<text top="491" left="45" width="243" height="9" font="font0" id="p1_t6" reading_order_no="17" segment_no="10" tag_type="text">adjustment for covariates (adjusted estimates in Table 2; p .</text>
<text top="503" left="45" width="243" height="8" font="font0" id="p1_t7" reading_order_no="18" segment_no="10" tag_type="text">0.10 for all; the intracluster correlation coefﬁcient for the</text>
<text top="514" left="45" width="243" height="8" font="font0" id="p1_t8" reading_order_no="19" segment_no="10" tag_type="text">cognitive function score was 0.212). The two groups were very</text>
<text top="526" left="45" width="243" height="8" font="font0" id="p1_t9" reading_order_no="20" segment_no="10" tag_type="text">similar in the proportion enrolled in school (unadjusted odds</text>
<text top="536" left="45" width="244" height="9" font="font0" id="p1_t10" reading_order_no="21" segment_no="10" tag_type="text">ratio ¼ 1.020, 95% conﬁdence interval [CI] 0.658 to 1.583; p ¼</text>
<text top="548" left="45" width="243" height="8" font="font0" id="p1_t11" reading_order_no="22" segment_no="10" tag_type="text">0.928; logistic regression), and adjustment for covariates was</text>
<text top="560" left="45" width="243" height="8" font="font0" id="p1_t12" reading_order_no="23" segment_no="10" tag_type="text">without effect (adjusted estimates in Table 2). However, there</text>
<text top="570" left="45" width="243" height="9" font="font0" id="p1_t13" reading_order_no="24" segment_no="10" tag_type="text">was a signiﬁcant ( p ¼ 0.013) interaction between school</text>
<text top="582" left="45" width="243" height="8" font="font0" id="p1_t14" reading_order_no="25" segment_no="10" tag_type="text">enrolment and female gender. In an adjusted model that</text>
<text top="594" left="45" width="243" height="8" font="font0" id="p1_t15" reading_order_no="26" segment_no="10" tag_type="text">included this interaction term, the odds ratios (95% CI) on</text>
<text top="604" left="45" width="243" height="9" font="font0" id="p1_t16" reading_order_no="27" segment_no="10" tag_type="text">the intervention (control ¼ 0 and prophylaxis ¼ 1), gender</text>
<text top="616" left="45" width="243" height="9" font="font0" id="p1_t17" reading_order_no="28" segment_no="10" tag_type="text">(male ¼ 0 and female ¼ 1), and the interaction were 0.674</text>
<text top="628" left="45" width="243" height="8" font="font0" id="p1_t18" reading_order_no="29" segment_no="10" tag_type="text">(0.383 to 1.184), 0.154 (0.087 to 0.272), and 2.773 (1.243 to</text>
<text top="639" left="45" width="243" height="8" font="font0" id="p1_t19" reading_order_no="30" segment_no="10" tag_type="text">6.193). Hence the intervention effect in boys was 0.674 (0.383</text>
<text top="650" left="45" width="243" height="9" font="font0" id="p1_t20" reading_order_no="31" segment_no="10" tag_type="text">to 1.184; p ¼ 0.170) and in girls was 0.674 3 2.773 ¼ 1.869</text>
<text top="661" left="45" width="243" height="9" font="font0" id="p1_t21" reading_order_no="32" segment_no="10" tag_type="text">(0.943 to 3.702; p ¼ 0.073). The prophylaxis appeared to</text>
<text top="673" left="45" width="243" height="8" font="font0" id="p1_t22" reading_order_no="33" segment_no="10" tag_type="text">increase the odds that the girls attended school and decrease</text>
<text top="685" left="45" width="243" height="8" font="font0" id="p1_t23" reading_order_no="34" segment_no="10" tag_type="text">the odds that the boys attended school, though these effects</text>
<text top="696" left="45" width="146" height="8" font="font0" id="p1_t24" reading_order_no="35" segment_no="10" tag_type="text">did not reach statistical signiﬁcance.</text>
<text top="707" left="54" width="234" height="8" font="font0" id="p1_t25" reading_order_no="36" segment_no="13" tag_type="text">The prophylaxis group’s mean educational attainment was</text>
<text top="719" left="45" width="243" height="8" font="font0" id="p1_t26" reading_order_no="37" segment_no="13" tag_type="text">4.47 grades at school compared to the placebo group’s 3.81.</text>
<text top="426" left="306" width="243" height="8" font="font0" id="p1_t27" reading_order_no="38" segment_no="8" tag_type="text">Unadjusted regression analysis gave a mean attainment 0.65</text>
<text top="437" left="306" width="243" height="9" font="font0" id="p1_t28" reading_order_no="39" segment_no="8" tag_type="text">grades higher in the intervention arm (0.023 to 1.276; p ¼ 0.042).</text>
<text top="448" left="306" width="243" height="9" font="font0" id="p1_t29" reading_order_no="40" segment_no="8" tag_type="text">This estimate was reduced slightly to 0.52 ( p ¼ 0.069; Table 2)</text>
<text top="460" left="306" width="243" height="8" font="font0" id="p1_t30" reading_order_no="41" segment_no="8" tag_type="text">when covariates were included in the analysis. Estimates were</text>
<text top="472" left="306" width="199" height="8" font="font0" id="p1_t31" reading_order_no="42" segment_no="8" tag_type="text">similar using ordinal logistic regression (Table S2).</text>
<text top="490" left="306" width="82" height="10" font="font1" id="p1_t32" reading_order_no="43" segment_no="11" tag_type="title">Ancillary Analyses</text>
<text top="503" left="306" width="243" height="8" font="font0" id="p1_t33" reading_order_no="44" segment_no="12" tag_type="text">Supplementary analyses were conducted, stratiﬁed by num-</text>
<text top="514" left="306" width="243" height="8" font="font0" id="p1_t34" reading_order_no="45" segment_no="12" tag_type="text">ber of years children were eligible for post-trial prophylaxis.</text>
<text top="526" left="306" width="243" height="8" font="font0" id="p1_t35" reading_order_no="46" segment_no="12" tag_type="text">For the cognitive function score, there was a signiﬁcant</text>
<text top="537" left="306" width="243" height="8" font="font0" id="p1_t36" reading_order_no="47" segment_no="12" tag_type="text">interaction between the four sub-groups and the trial</text>
<text top="548" left="306" width="243" height="9" font="font0" id="p1_t37" reading_order_no="48" segment_no="12" tag_type="text">intervention ( p ¼ 0.034), with larger treatment effects for</text>
<text top="560" left="306" width="243" height="8" font="font0" id="p1_t38" reading_order_no="49" segment_no="12" tag_type="text">the two groups that spent the longest on trial and received</text>
<text top="571" left="306" width="243" height="8" font="font0" id="p1_t39" reading_order_no="50" segment_no="12" tag_type="text">the least post-trial prophylaxis (Table 3). There was a small</text>
<text top="582" left="306" width="243" height="8" font="font0" id="p1_t40" reading_order_no="51" segment_no="12" tag_type="text">effect (0.264, or, in units of SD, approximately 0.24 SD, 95%</text>
<text top="594" left="306" width="9" height="8" font="font0" id="p1_t41" reading_order_no="52" segment_no="12" tag_type="text">CI</text>
<text top="594" left="324" width="225" height="8" font="font0" id="p1_t42" reading_order_no="53" segment_no="12" tag_type="text">0.03 to 0.51) in the group of individuals that were not</text>
<text top="605" left="306" width="243" height="8" font="font0" id="p1_t43" reading_order_no="54" segment_no="12" tag_type="text">eligible for post-trial prophylaxis and spent 3 y in the trial,</text>
<text top="616" left="306" width="243" height="8" font="font0" id="p1_t44" reading_order_no="55" segment_no="12" tag_type="text">and a somewhat larger effect (0.43 SD, 95% CI 0.10 to 0.77)</text>
<text top="628" left="306" width="243" height="8" font="font0" id="p1_t45" reading_order_no="56" segment_no="12" tag_type="text">among those eligible for less than 1 y of post-trial prophylaxis</text>
<text top="639" left="306" width="243" height="8" font="font0" id="p1_t46" reading_order_no="57" segment_no="12" tag_type="text">and who were in the trial for all 4 y. There was no effect</text>
<text top="650" left="306" width="243" height="8" font="font0" id="p1_t47" reading_order_no="58" segment_no="12" tag_type="text">among those eligible for more than 1 y of post-trial</text>
<text top="662" left="306" width="243" height="8" font="font0" id="p1_t48" reading_order_no="59" segment_no="12" tag_type="text">prophylaxis. For both educational measures, there was no</text>
<text top="673" left="306" width="243" height="8" font="font0" id="p1_t49" reading_order_no="60" segment_no="12" tag_type="text">signiﬁcant interaction between years of post-trial prophylaxis</text>
<text top="685" left="306" width="243" height="8" font="font0" id="p1_t50" reading_order_no="61" segment_no="12" tag_type="text">and treatment, but the pattern of results for the highest grade</text>
<text top="696" left="306" width="243" height="8" font="font0" id="p1_t51" reading_order_no="62" segment_no="12" tag_type="text">reached (Table 3) was similar to that found for cognitive</text>
<text top="707" left="306" width="243" height="8" font="font0" id="p1_t52" reading_order_no="63" segment_no="12" tag_type="text">function, with the largest effects for sub-groups receiving less</text>
<text top="719" left="306" width="135" height="8" font="font0" id="p1_t53" reading_order_no="64" segment_no="12" tag_type="text">than 1 y of post-trial prophylaxis.</text>
<text top="309" left="45" width="290" height="7" font="font5" id="p1_t54" reading_order_no="1" segment_no="1" tag_type="text">Figure 1. Participant Flow in Follow-Up to Chemoprophylaxis Cluster-Controlled Trial</text>
<text top="322" left="45" width="504" height="7" font="font7" id="p1_t55" reading_order_no="2" segment_no="2" tag_type="text">Participant flow in the malaria chemoprophylaxis trial and follow-up 11 y later. Fifteen villages took part in the trial, with treatment allocated systematically by</text>
<text top="331" left="45" width="504" height="7" font="font7" id="p1_t56" reading_order_no="3" segment_no="2" tag_type="text">compound. Follow-up was conducted in the ten villages that completed the trial. Children who completed a whole year of the trial were selected to take part in</text>
<text top="340" left="45" width="44" height="7" font="font7" id="p1_t57" reading_order_no="4" segment_no="2" tag_type="text">the follow-up.</text>
<text top="348" left="45" width="376" height="8" font="font7" id="p1_t58" reading_order_no="5" segment_no="3" tag_type="text">1 The village health worker died in one village and was dismissed in another. Drugs were insufficient in three villages.</text>
<text top="357" left="45" width="504" height="8" font="font7" id="p1_t59" reading_order_no="6" segment_no="4" tag_type="text">2 Only children participating in at least one complete transmission season were selected for tracing. Some compounds contained both children selected and</text>
<text top="367" left="45" width="69" height="7" font="font7" id="p1_t60" reading_order_no="7" segment_no="4" tag_type="text">children not selected.</text>
<text top="375" left="45" width="504" height="8" font="font7" id="p1_t61" reading_order_no="8" segment_no="5" tag_type="text">3 One child refused and one child failed to understand cognitive test instructions in the placebo group. One child refused and two failed to understand</text>
<text top="385" left="45" width="120" height="7" font="font7" id="p1_t62" reading_order_no="9" segment_no="5" tag_type="text">instructions in the prophylaxis group.</text>
<text top="393" left="45" width="490" height="8" font="font7" id="p1_t63" reading_order_no="10" segment_no="6" tag_type="text">* Intervention group allocation was by compound, trial completion was on a village basis, and selection for tracing was conducted for individual children.</text>
<text top="403" left="45" width="124" height="7" font="font7" id="p1_t64" reading_order_no="11" segment_no="6" tag_type="text">DOI: 10.1371/journal.pctr.0010019.g001</text>
<text top="742" left="45" width="85" height="7" font="font6" id="p1_t65" reading_order_no="65" segment_no="14" tag_type="text">www.plosclinicaltrials.org</text>
<text top="742" left="482" width="67" height="7" font="font6" id="p1_t66" reading_order_no="67" segment_no="15" tag_type="text">August | 2006 | e19</text>
<text top="742" left="289" width="16" height="7" font="font6" id="p1_t67" reading_order_no="66" segment_no="16" tag_type="text">0005</text>
<text top="26" left="427" width="122" height="7" font="font6" id="p1_t68" reading_order_no="0" segment_no="0" tag_type="title">Malaria and Cognitive Development</text>
</page>
</pdf2xml>
